SUPPLEMENTAL INFORMATION Acute graft-versus-host disease presenting as Stevens–Johnson syndrome and toxic epidermal necrolysis: a retrospective cohort study

Published: 10 November 2022| Version 3 | DOI: 10.17632/24dssxsfp9.3
Contributor:
Yi-Teng Hung

Description

Supplemental material for Manuscript: Acute graft-versus-host disease presenting as Stevens–Johnson syndrome and toxic epidermal necrolysis: a retrospective cohort study (JAAD-D-22-00806R1) Supplemental Method and Material. Methods and materials for immunohistochemistry. Supplemental Table I. Immunohistochemical analyses of skin biopsy samples from non-Stevens–Johnson syndrome (SJS)/toxic epidermal necrolysis (TEN)-like acute graft-versus-host disease (aGVHD) patients and SJS/TEN-like aGVHD patients. Supplemental Table II. Treatment and prognosis for acute graft-versus-host disease with/without Stevens–Johnson syndrome and toxic epidermal necrolysis symptoms. Supplemental Figure 1. Clinical pictures of a patient with Stevens–Johnson syndrome/toxic epidermal necrolysis-like acute graft-versus-host disease. Supplemental Figure 2. Histopathology of skin lesions of Stevens–Johnson syndrome (SJS)/toxic epidermal necrolysis (TEN)-like acute graft-versus-host disease (aGVHD). Supplemental Figure 3. Comparison of immunohistochemistry on skin biopsy samples from non-Stevens–Johnson syndrome (SJS)/toxic epidermal necrolysis (TEN)-like acute graft-versus-host disease (aGVHD) patients and SJS/TEN-like aGVHD patients. Supplemental Figure 4. Kaplan–Meier curves for probability of survival in acute graft-versus-host disease patients.

Files

Institutions

Chang Gung Memorial Hospital Linkou Branch

Categories

Cohort Study, Steven-Johnson Syndrome, Complication, Prognosis, Skin Rash, Supplementation, Graft-versus-Host Disease, Toxic Epidermal Necrolysis

License